HBT Financial, Inc. Announces First Quarter 2024 Financial Results
First Quarter Highlights Net income of $15.3 million, or $0.48 per diluted share; return on average assets (“ROAA”) of 1.23%; return […]
BioCryst to Report First Quarter 2024 Financial Results on May 6
RESEARCH TRIANGLE PARK, N.C., April 22, 2024 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will […]
Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense
Plus now has $23 million in active awards support for the Company’s targeted radiotherapeutic pipeline Funding for pediatric brain cancer […]
BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its Market Potential
Company plans to initiate SERENITY At-Home pivotal Phase 3 safety trial with 120 mcg dose following recent meeting with FDA […]
Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024
BOSTON and LONDON, April 22, 2024 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims […]
Balchem Corporation Releases 2023 Sustainability Report
MONTVALE, N.J., April 22, 2024 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) today published its 2023 Sustainability Report, highlighting the […]
Capital City Bank Group, Inc. Reports First Quarter 2024 Results
TALLAHASSEE, Fla., April 22, 2024 (GLOBE NEWSWIRE) — Capital City Bank Group, Inc. (NASDAQ: CCBG) today reported net income attributable […]
Comscore to Announce First Quarter 2024 Financial Results
RESTON, Va., April 22, 2024 (GLOBE NEWSWIRE) — Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting and evaluating […]
Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
PHILADELPHIA, April 22, 2024 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving […]
Kaspi.kz 1Q 2024 Financial Results
ALMATY, Kazakhstan, April 22, 2024 (GLOBE NEWSWIRE) — Joint Stock Company Kaspi.kz (“Kaspi.kz”, “we”, or the “Company”) (Nasdaq: KSPI) which […]
